4
Changes in Ownership
Passage BIO, Inc. Filed Acc 0001415889-25-003728
CFO sold 3,183 shares at $0.53 ($1,686)
- CFO acquired 8,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Borthwick Kathleen CFO | 2025-02-10 | Option exercise | +8,000 | 44,466 | D | ||
| Borthwick Kathleen CFO | 2025-02-11 | Sale | −3,183 | $0.53 | $1,686 | 41,283 | D |
| Derivatives | |||||||
| Borthwick Kathleen CFO | 2025-02-10 | Option exercise · Restricted Stock Unit | −8,000 | 0 | D | ||
| Open-market sales · 3,183 sh · avg $0.53 · $1,686 | |||||||
Loading xslF345X05/form4-02122025_090233.xml…